Written Question · S4W-23513 · Session 4
What its position is on including the meningitis B vaccine in the national immunisation programme.
The question
To ask the Scottish Government what its position is on including the meningitis B vaccine in the national immunisation programme.
The answer
The Scottish Government is delighted that the Joint Committee on Vaccination and Immunisation (JCVI) has identified the importance of introducing a vaccine against meningitis B and welcomes the JCVI’s recommendation to introduce a meningitis B vaccination programme to the primary infant immunisation schedule at two, four and 12 months of age.
The first step involves determining whether the vaccine can be procured at a cost-effective price, as the JCVI is recommending. This is a matter for negotiation with the manufacturers. The UK Department of Health procures vaccine on behalf of all four UK countries and is currently in negotiations with the manufacturer Novartis to seek to agree a cost-effective price for the supply of the meningococcal B vaccine, Bexsero.
The first step involves determining whether the vaccine can be procured at a cost-effective price, as the JCVI is recommending. This is a matter for negotiation with the manufacturers. The UK Department of Health procures vaccine on behalf of all four UK countries and is currently in negotiations with the manufacturer Novartis to seek to agree a cost-effective price for the supply of the meningococcal B vaccine, Bexsero.
In the Official Report
No contribution in the Official Report cites S4W-23513 by reference.